Related references
Note: Only part of the references are listed.Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab
Srilakshmi Bathini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
Katie Sackett et al.
JOURNAL OF CLINICAL APHERESIS (2018)
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation
Claudia I. Chapuy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation
F. Khan et al.
TRANSFUSION MEDICINE (2014)
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
CD Bolan et al.
BLOOD (2001)
Share Paper
